Cargando…

The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension

BACKGROUND: The role of microRNAs (miRNAs) in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension (SSc-PAH) remains to be fully elucidated. This study evaluated the expression profile of miRNAs in the lung tissue of patients with SSc-PAH. METHODS: Lung tissue samples we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu-Xia, Li, Fei, Liu, Dong, Sun, Yuan-Yuan, Zhao, Qin-Hua, Jiang, Rong, Wang, Lan, Yuan, Ping, Liu, Jin-Ming, Wu, Yue, Zhang, Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506742/ https://www.ncbi.nlm.nih.gov/pubmed/34734010 http://dx.doi.org/10.21037/atm-21-4342

Ejemplares similares

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
por: Wuttge, Dirk M, et al.
Publicado: (2021)

Therapeutic implications of microRNAs in pulmonary arterial hypertension
por: Lee, Aram, et al.
Publicado: (2014)

MicroRNA-17 as a potential diagnostic biomarker in pulmonary arterial hypertension
por: Li, Haiwen, et al.
Publicado: (2020)

New hope for a microRNA therapy for pulmonary arterial hypertension
por: Mehta, Jyoti, et al.
Publicado: (2013)

Differential expression of microRNA in the lungs of rats with pulmonary arterial hypertension
por: Xiao, Tingting, et al.
Publicado: (2017)

MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

MicroRNA‐483 amelioration of experimental pulmonary hypertension
por: Zhang, Jin, et al.
Publicado: (2020)

Alteration of Extracellular Superoxide Dismutase in Idiopathic Pulmonary Arterial Hypertension
por: Zhang, Rui, et al.
Publicado: (2020)

Prognostic Value of Follicle-Stimulating Hormone Levels in Predicting Survival in Men With Idiopathic Pulmonary Arterial Hypertension
por: Wang, Qian, et al.
Publicado: (2022)

Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study
por: Gong, Su-Gang, et al.
Publicado: (2018)

The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension
por: Wei, Yaqin, et al.
Publicado: (2023)

Expression of the microRNA-30 family in pulmonary arterial hypertension and the role of microRNA-30d-5p in the regulation of pulmonary arterial smooth muscle cell toxicity and apoptosis
por: Hu, Fan, et al.
Publicado: (2022)

Diffuse Pulmonary Arteriovenous Fistulas With Pulmonary Arterial Hypertension: Case Report and Review
por: Jiang, Rong, et al.
Publicado: (2016)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension
por: Li, Yuan, et al.
Publicado: (2022)

Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients
por: Pudasaini, Bigyan, et al.
Publicado: (2018)

Sex-specific cardiopulmonary exercise testing indices related to hemodynamics in idiopathic pulmonary arterial hypertension
por: Yuan, Ping, et al.
Publicado: (2017)

Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension
por: Lv, Zhen-Chun, et al.
Publicado: (2021)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

MicroRNAs in pulmonary arterial remodeling
por: Grant, Jennifer S., et al.
Publicado: (2013)

MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment
por: Xu, Junhua, et al.
Publicado: (2022)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
por: Ma, Wenrui, et al.
Publicado: (2021)

Identification of Hub Genes and MicroRNAs Associated With Idiopathic Pulmonary Arterial Hypertension by Integrated Bioinformatics Analyses
por: Qiu, Xue, et al.
Publicado: (2021)

Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension
por: Huang, Yang, et al.
Publicado: (2021)

Differences in disease severity and prognosis of exercise-induced right-to-left shunt between idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients
por: Wang, Shang, et al.
Publicado: (2022)

Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Li, Jie, et al.
Publicado: (2022)

Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension
por: Liu, HaiTao, et al.
Publicado: (2017)

Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension
por: DÜZGÜN, Zekeriya, et al.
Publicado: (2022)

The Role of Regulatory T Cells in Pulmonary Arterial Hypertension
por: Qiu, Haihua, et al.
Publicado: (2019)

The effect of docosahexaenoic acid on predicting the survival of patients with idiopathic pulmonary arterial hypertension
por: Huai, Xu, et al.
Publicado: (2021)

Increased Levels of Runt-Related Transcription Factor 2 Are Associated With Poor Survival of Patients With Idiopathic Pulmonary Arterial Hypertension
por: Yuan, Xuntao, et al.
Publicado: (2020)

Right Ventricle to Pulmonary Artery Coupling Predicts the Risk Stratification in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
por: Lai, Jinzhi, et al.
Publicado: (2022)

Elevated microRNA-135a is associated with pulmonary arterial hypertension in experimental mouse model
por: Lee, Hyun-Wook, et al.
Publicado: (2017)

Editorial: Calcium and pulmonary hypertension
por: Li, Ji-Feng, et al.
Publicado: (2022)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
por: Almaaitah, Saja, et al.
Publicado: (2020)

Echocardiographic Prognosis Relevance of Attenuated Right Heart Remodeling in Idiopathic Pulmonary Arterial Hypertension
por: Zhao, Qin-Hua, et al.
Publicado: (2021)

Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA‐328‐3p/profilin 1 axis
por: Yang, Chengpeng, et al.
Publicado: (2022)

Cognitive Dysfunction in Patients with Pulmonary Hypertension
por: Yuan, Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g7gdvlcruc8lcv7gj7d24f2u5u